Jazz Pharmaceuticals to Participate in Upcoming September Investor Conferences
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) has announced its participation in two upcoming investor conferences in September 2024. The company will be present at the Wells Fargo Healthcare Conference on September 4, with a fireside chat at 7:15 a.m. PT, and the Bank of America Global Healthcare Conference on September 18, with a fireside chat at 7:55 a.m. PT.
Audio webcasts of both events will be available on the Jazz Pharmaceuticals website's Investors section, with replays archived for 30 days. Jazz Pharmaceuticals is a global biopharma company focused on developing life-changing medicines for serious diseases, with a portfolio including therapies for sleep disorders, epilepsy, and cancer. The company is headquartered in Dublin, Ireland, with operations and employees worldwide.
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) ha annunciato la sua partecipazione a due conferenze per investitori in programma a settembre 2024. L'azienda sarà presente al Wells Fargo Healthcare Conference il 4 settembre, con una chiacchierata informale alle 7:15 a.m. PT, e al Bank of America Global Healthcare Conference il 18 settembre, con una chiacchierata informale alle 7:55 a.m. PT.
I webcast audio di entrambi gli eventi saranno disponibili nella sezione Investitori del sito web di Jazz Pharmaceuticals, con le riprese archiviate per 30 giorni. Jazz Pharmaceuticals è un'azienda biopharma globale focalizzata nello sviluppo di farmaci che cambiano la vita per malattie gravi, con un portafoglio che include terapie per disturbi del sonno, epilessia e cancro. L'azienda ha sede a Dublino, Irlanda, con operazioni e dipendenti in tutto il mondo.
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) ha anunciado su participación en dos conferencias de inversores programadas para septiembre de 2024. La compañía estará presente en la Wells Fargo Healthcare Conference el 4 de septiembre, con una charla informal a las 7:15 a.m. PT, y en la Bank of America Global Healthcare Conference el 18 de septiembre, con una charla informal a las 7:55 a.m. PT.
Las retransmisiones de audio de ambos eventos estarán disponibles en la sección de Inversores del sitio web de Jazz Pharmaceuticals, con repeticiones archivadas durante 30 días. Jazz Pharmaceuticals es una empresa biopharma global centrada en el desarrollo de medicamentos que cambian la vida para enfermedades graves, con un portafolio que incluye terapias para trastornos del sueño, epilepsia y cáncer. La empresa tiene su sede en Dublín, Irlanda, con operaciones y empleados en todo el mundo.
Jazz Pharmaceuticals plc (Nasdaq: JAZZ)는 2024년 9월 두 개의 투자자 회의에 참석할 것이라고 발표했습니다. 회사는 9월 4일에 열리는 웰스 파고 헬스케어 컨퍼런스에 참석하며, 오전 7:15 PT에 비공식 대담이 예정되어 있습니다. 또한 9월 18일에는 메리랜드 뱅크 글로벌 헬스케어 컨퍼런스에 참석하며, 오전 7:55 PT에 대담이 진행됩니다.
두 이벤트의 오디오 웹캐스트는 Jazz Pharmaceuticals 웹사이트의 투자자 섹션에서 이용 가능하며, 30일 동안 다시 볼 수 있습니다. Jazz Pharmaceuticals는 심각한 질병에 대한 생명을 변화시키는 의약품 개발에 주력하는 글로벌 생명과학 기업으로, 수면 장애, 간질, 암 치료제를 포함하는 포트폴리오를 보유하고 있습니다. 이 회사는 아일랜드 더블린에 본사를 두고 있으며, 전 세계에 운영 및 직원을 두고 있습니다.
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) a annoncé sa participation à deux conférences pour investisseurs prévues en septembre 2024. L'entreprise sera présente à la Wells Fargo Healthcare Conference le 4 septembre, avec une discussion informelle à 7h15 PT, et à la Bank of America Global Healthcare Conference le 18 septembre, avec une discussion à 7h55 PT.
Des webcasts audio des deux événements seront disponibles dans la section Investisseurs du site Web de Jazz Pharmaceuticals, avec des rediffusions archivées pendant 30 jours. Jazz Pharmaceuticals est une entreprise biopharmaceutique mondiale qui se concentre sur le développement de médicaments capables de changer la vie pour des maladies graves, avec un portefeuille incluant des thérapies pour les troubles du sommeil, l'épilepsie et le cancer. L'entreprise a son siège à Dublin, en Irlande, et dispose d'opérations et d'employés dans le monde entier.
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im September 2024 angekündigt. Das Unternehmen wird am 4. September beim Wells Fargo Healthcare Conference anwesend sein, mit einem informellen Gespräch um 7:15 Uhr PT, und beim Bank of America Global Healthcare Conference am 18. September, mit einem Gespräch um 7:55 Uhr PT.
Die Audio-Webcasts beider Veranstaltungen sind im Investorenbereich der Website von Jazz Pharmaceuticals verfügbar, und alle Aufzeichnungen werden für 30 Tage archiviert. Jazz Pharmaceuticals ist ein globales Biopharmaunternehmen, das sich auf die Entwicklung von lebensverändernden Medikamenten für schwere Krankheiten konzentriert, mit einem Portfolio, das Therapien für Schlafstörungen, Epilepsie und Krebs umfasst. Das Unternehmen hat seinen Hauptsitz in Dublin, Irland, und verfügt über Betriebe und Mitarbeiter weltweit.
- None.
- None.
Wells Fargo Healthcare Conference on Wednesday, September 4, 2024
- Fireside chat at 7:15 a.m. PT / 10:15 a.m. ET / 3:15 p.m. IST
Bank of America Global Healthcare Conference on Wednesday, September 18, 2024
- Fireside chat at 7:55 a.m. PT / 10:55 a.m. ET / 3:55 p.m. IST
Audio webcasts of the fireside chats will be available via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations. A replay of the webcasts will be archived on the website for 30 days.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in
Contacts:
Investors:
Andrea N. Flynn, Ph.D.
Vice President, Head, Investor Relations
Jazz Pharmaceuticals plc
InvestorInfo@jazzpharma.com
Media:
Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
CorporateAffairsMediaInfo@jazzpharma.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-participate-in-upcoming-september-investor-conferences-302226923.html
SOURCE Jazz Pharmaceuticals plc
FAQ
When is Jazz Pharmaceuticals (JAZZ) participating in the Wells Fargo Healthcare Conference in 2024?
What time is Jazz Pharmaceuticals' (JAZZ) fireside chat at the Bank of America Global Healthcare Conference in September 2024?
Where can investors access the webcasts of Jazz Pharmaceuticals' (JAZZ) September 2024 conference presentations?
How long will the replays of Jazz Pharmaceuticals' (JAZZ) September 2024 investor conference webcasts be available?
What are the main therapeutic areas Jazz Pharmaceuticals (JAZZ) focuses on?
